• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CHRIS 研究中的十年动态同意:知情同意作为一个动态过程。

Ten years of dynamic consent in the CHRIS study: informed consent as a dynamic process.

机构信息

Institute for Biomedicine, Eurac Research, Affiliated Institute of the University of Lübeck, Bolzano, Italy.

Center for Research Ethics and Bioethics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.

出版信息

Eur J Hum Genet. 2022 Dec;30(12):1391-1397. doi: 10.1038/s41431-022-01160-4. Epub 2022 Sep 5.

DOI:10.1038/s41431-022-01160-4
PMID:36064788
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9441838/
Abstract

The Cooperative Health Research in South Tyrol (CHRIS) is a longitudinal study in Northern Italy, using dynamic consent since its inception in 2011. The CHRIS study collects health data and biosamples for research, and foresees regular follow-ups over time. We describe the experience with the CHRIS study dynamic consent, providing an overview of its conceptualization and implementation, and of the participant-centered strategies used to assess and improve the process, directly linked to participation and communication. In order to comply with high ethical standards and to allow broadness in the areas of research, CHRIS dynamic consent was conceived as an interactive process: based on a strong governance and an ongoing tailored communication with participants, it aims to promote autonomy and to develop a trust-based engaged relationship with participants, also relevant for retention. Built within an online platform, the consent allows granular choices, which can be changed over time. In a process of co-production, participants views have been investigated and kept into account in policy development. Participants showed a high degree of participation, thus enabling the consolidation of the CHRIS resources. Even though a low change rate was reported in the baseline, participants valued the possibility of changing their informed consent choices. Communication (language-tailored, ongoing, multimedia) was important for participants, and for participation and retention. In our experience, dynamic consent was proven to be a flexible consent model, which allowed to meet ethical and legal standards for participation in research, and to accommodate participants' and researchers' needs.

摘要

南蒂罗尔合作健康研究(CHRIS)是意大利北部的一项纵向研究,自 2011 年成立以来一直采用动态同意。CHRIS 研究收集健康数据和生物样本用于研究,并预计随着时间的推移进行定期随访。我们描述了 CHRIS 研究动态同意的经验,提供了其概念化和实施的概述,以及用于评估和改进与参与和沟通直接相关的过程的以参与者为中心的策略。为了遵守高标准的伦理准则并允许在研究领域广泛开展,CHRIS 动态同意被视为一个互动过程:基于强大的治理和与参与者的持续定制沟通,它旨在促进自主性,并与参与者建立基于信任的参与关系,这对保留也很重要。该同意书构建在在线平台内,允许进行细粒度的选择,并可以随着时间的推移进行更改。在共同制定政策的过程中,参与者的意见得到了调查并被考虑在内。参与者表现出高度的参与度,从而巩固了 CHRIS 的资源。尽管在基线报告中报告了低变化率,但参与者重视更改其知情同意选择的可能性。沟通(语言定制、持续、多媒体)对参与者和参与度和保留度很重要。根据我们的经验,动态同意被证明是一种灵活的同意模式,它允许满足参与研究的伦理和法律标准,并满足参与者和研究人员的需求。

相似文献

1
Ten years of dynamic consent in the CHRIS study: informed consent as a dynamic process.CHRIS 研究中的十年动态同意:知情同意作为一个动态过程。
Eur J Hum Genet. 2022 Dec;30(12):1391-1397. doi: 10.1038/s41431-022-01160-4. Epub 2022 Sep 5.
2
Balancing scientific interests and the rights of participants in designing a recall by genotype study.在设计基于基因型的召回研究时,平衡科学利益和参与者的权利。
Eur J Hum Genet. 2021 Jul;29(7):1146-1157. doi: 10.1038/s41431-021-00860-7. Epub 2021 May 13.
3
American Society of Clinical Oncology policy statement: oversight of clinical research.美国临床肿瘤学会政策声明:临床研究监督
J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.
4
Views of US researchers about informed consent in international collaborative research.美国研究人员对国际合作研究中知情同意的看法。
Soc Sci Med. 2005 Sep;61(6):1211-22. doi: 10.1016/j.socscimed.2005.02.004. Epub 2005 Apr 9.
5
Dynamic Consent: a potential solution to some of the challenges of modern biomedical research.动态同意:现代生物医学研究中一些挑战的潜在解决方案。
BMC Med Ethics. 2017 Jan 25;18(1):4. doi: 10.1186/s12910-016-0162-9.
6
Adding dynamic consent to a longitudinal cohort study: A qualitative study of EXCEED participant perspectives.将动态同意纳入纵向队列研究:关于EXCEED参与者观点的定性研究
BMC Med Ethics. 2021 Feb 9;22(1):12. doi: 10.1186/s12910-021-00583-w.
7
Dynamic Consent: An Evaluation and Reporting Framework.动态同意:评估与报告框架。
J Empir Res Hum Res Ethics. 2020 Jul;15(3):175-186. doi: 10.1177/1556264619887073. Epub 2019 Nov 15.
8
Participant perspective on the recall-by-genotype research approach: a mixed-method embedded study with participants of the CHRIS study.参与者对基于基因型召回研究方法的看法:一项采用 CHRIS 研究参与者的混合方法嵌入式研究。
Eur J Hum Genet. 2023 Nov;31(11):1218-1227. doi: 10.1038/s41431-022-01277-6. Epub 2023 Jan 4.
9
How to communicate and what to disclose to participants in a recall-by-genotype research approach: a multistep empirical study.如何在基于基因型的召回研究方法中与参与者进行沟通以及披露哪些信息:一项多步骤实证研究。
J Community Genet. 2024 Dec;15(6):615-630. doi: 10.1007/s12687-024-00733-8. Epub 2024 Sep 26.
10
[The origin of informed consent].[知情同意的起源]
Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27.

引用本文的文献

1
Cohort Profile: the Cooperative Health Research in South Tyrol study.队列简介:南蒂罗尔合作健康研究
Int J Epidemiol. 2025 Apr 12;54(3). doi: 10.1093/ije/dyaf064.
2
Privacy and Consent in Mobile Health: Solutions for Balancing Benefits and Risks.移动健康中的隐私与同意:平衡收益与风险的解决方案
Mayo Clin Proc Digit Health. 2024 May 21;2(3):331-334. doi: 10.1016/j.mcpdig.2024.05.005. eCollection 2024 Sep.
3
Insights From the Development of a Dynamic Consent Platform for the Australians Together Health Initiative (ATHENA) Program: Interview and Survey Study.澳大利亚团结健康倡议(ATHENA)项目动态知情同意平台开发的启示:访谈和调查研究。
JMIR Form Res. 2024 Nov 6;8:e57165. doi: 10.2196/57165.
4
How to communicate and what to disclose to participants in a recall-by-genotype research approach: a multistep empirical study.如何在基于基因型的召回研究方法中与参与者进行沟通以及披露哪些信息:一项多步骤实证研究。
J Community Genet. 2024 Dec;15(6):615-630. doi: 10.1007/s12687-024-00733-8. Epub 2024 Sep 26.
5
Opportunities and challenges of a dynamic consent-based application: personalized options for personal health data sharing and utilization.动态同意制应用的机遇与挑战:个性化选择实现个人健康数据的共享和利用。
BMC Med Ethics. 2024 Aug 31;25(1):92. doi: 10.1186/s12910-024-01091-3.
6
Dynamic governance: A new era for consent for stem cell research.动态治理:干细胞研究同意的新时代。
Stem Cell Reports. 2024 Sep 10;19(9):1233-1241. doi: 10.1016/j.stemcr.2024.07.006. Epub 2024 Aug 15.
7
Ethical framework for FACILITATE: a foundation for the return of clinical trial data to participants.促进临床试验数据返还参与者的伦理框架:基础
Front Med (Lausanne). 2024 Jul 17;11:1408600. doi: 10.3389/fmed.2024.1408600. eCollection 2024.
8
Artificial Intelligence Needs Data: Challenges Accessing Italian Databases to Train AI.人工智能需要数据:访问意大利数据库以训练人工智能所面临的挑战
Asian Bioeth Rev. 2024 Jun 13;16(3):423-435. doi: 10.1007/s41649-024-00282-9. eCollection 2024 Jul.
9
Future-proofing genomic data and consent management: a comprehensive review of technology innovations.未来基因组数据和知情同意管理:技术创新的综合评述。
Gigascience. 2024 Jan 2;13. doi: 10.1093/gigascience/giae021.
10
Cross-border data sharing for research in Africa: An analysis of the data protection and research ethics requirements in 12 jurisdictions.非洲研究中的跨境数据共享:对12个司法管辖区的数据保护和研究伦理要求的分析
Res Sq. 2024 Apr 15:rs.3.rs-4217849. doi: 10.21203/rs.3.rs-4217849/v1.

本文引用的文献

1
Return of research results (RoRR) to the healthy CHRIS cohort: designing a policy with the participants.向健康的CHRIS队列返回研究结果(RoRR):与参与者共同制定一项政策。
J Community Genet. 2021 Oct;12(4):577-592. doi: 10.1007/s12687-021-00536-1. Epub 2021 Jul 9.
2
Balancing scientific interests and the rights of participants in designing a recall by genotype study.在设计基于基因型的召回研究时,平衡科学利益和参与者的权利。
Eur J Hum Genet. 2021 Jul;29(7):1146-1157. doi: 10.1038/s41431-021-00860-7. Epub 2021 May 13.
3
Task matters - challenging the motor system allows distinguishing unaffected Parkin mutation carriers from mutation-free controls.任务很重要——挑战运动系统可以将未受影响的 Parkin 基因突变携带者与无突变对照区分开来。
Parkinsonism Relat Disord. 2021 May;86:101-104. doi: 10.1016/j.parkreldis.2021.03.028. Epub 2021 Apr 20.
4
Reflections on dynamic consent in biomedical research: the story so far.关于生物医学研究中动态同意的思考:迄今为止的故事。
Eur J Hum Genet. 2021 Apr;29(4):649-656. doi: 10.1038/s41431-020-00771-z. Epub 2020 Nov 28.
5
Assessing the stability of biobank donor preferences regarding sample use: evidence supporting the value of dynamic consent.评估生物库捐赠者对样本使用偏好的稳定性:支持动态同意价值的证据。
Eur J Hum Genet. 2020 Sep;28(9):1168-1177. doi: 10.1038/s41431-020-0625-9. Epub 2020 Apr 23.
6
Authority and the Future of Consent in Population-Level Biomedical Research.群体层面生物医学研究中的同意权与未来
Public Health Ethics. 2019 Oct 30;12(3):225-236. doi: 10.1093/phe/phz015. eCollection 2019 Nov.
7
Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study.肠道微生物群、2 型糖尿病和非酒精性脂肪性肝病:一项观察性研究方案。
J Transl Med. 2019 Dec 4;17(1):408. doi: 10.1186/s12967-019-02130-z.
8
Dynamic Consent: An Evaluation and Reporting Framework.动态同意:评估与报告框架。
J Empir Res Hum Res Ethics. 2020 Jul;15(3):175-186. doi: 10.1177/1556264619887073. Epub 2019 Nov 15.
9
Effects of smoking status, history and intensity on heart rate variability in the general population: The CHRIS study.吸烟状况、吸烟史和吸烟强度对普通人群心率变异性的影响:CHRIS 研究。
PLoS One. 2019 Apr 9;14(4):e0215053. doi: 10.1371/journal.pone.0215053. eCollection 2019.
10
Equitable Participation in Biobanks: The Risks and Benefits of a "Dynamic Consent" Approach.生物样本库中的公平参与:“动态同意”方法的风险与益处
Front Public Health. 2018 Sep 5;6:253. doi: 10.3389/fpubh.2018.00253. eCollection 2018.